Virios Therapeutics, Inc.

  • About Virios
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Corporate Presentation
  • Target Diseases
    • Fibromyalgia
    • Long Covid
    • Blog
  • Pipeline
    • Pipeline
    • Presentations and Publications
  • Investors
  • News
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News
    • Press Releases
    • Email Alerts
  • Events & Presentations
    • Events
    • Presentations
    • Shareholder Letters
    • Meeting
  • Governance
    • Overview
    • Leadership
    • Board of Directors
    • Board Committees
    • Governance Documents
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Financial & Stock Info
    • Overview
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • Resources
    • Overview
    • IR Contacts
    • FAQ
    • Email Alerts
  • News

  • Press Releases
  • Email Alerts
May 13, 2021 7:05am EDT

Virios Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update

May 07, 2021 7:05am EDT

Virios Therapeutics to Present at the Benzinga Global Small Cap Conference

May 06, 2021 7:05am EDT

Virios Therapeutics to Report First Quarter 2021 Financial Results and Provide Corporate Update on Thursday, May 13, 2021

Apr 16, 2021 7:05am EDT

Virios Therapeutics, Inc. Interview to Air on Bloomberg Television U.S. on the RedChip Money Report

Apr 07, 2021 7:05am EDT

Virios Therapeutics to Present at the Needham Virtual Healthcare Conference

Mar 18, 2021 7:05am EDT

Virios Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

Mar 11, 2021 7:05am EST

Virios Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update on Thursday, March 18, 2021

Feb 24, 2021 7:05am EST

Virios Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference in March 2021

Feb 01, 2021 7:05am EST

Virios Therapeutics, Inc. Announces Research Collaboration to Explore Role of HSV-1 in Irritable Bowel Syndrome

Jan 28, 2021 9:15am EST

Virios Therapeutics to Present at the BIO CEO & Investor Conference

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

© 2023 Virios Therapeutics, Inc.           Terms and Conditions Privacy Policy Social Media Guidelines